Table 3 Duration of progression to IHD in the SLE and control group
Group | Interval (year) | Log-Rank test | Survival (%) | Failure (%) | Survival SE (‰) | Evaluated at the midpoint of the interval | |
|---|---|---|---|---|---|---|---|
Hazard | Hazard SE | ||||||
SLE | 490.1264* | ||||||
0–3 | 1 | 0 | 0 | 0.001015 | 0.000089 | ||
3–6 | 99.7 | 0.30 | 0.266 | 0.002568 | 0.000142 | ||
6–9 | 98.9 | 1.07 | 0.499 | 0.005722 | 0.000215 | ||
9–12 | 97.3 | 2.75 | 0.796 | 0.002551 | 0.000146 | ||
12 | 96.5 | 3.49 | 0.896 | . | . | ||
Control | |||||||
0–3 | 1 | 0 | 0 | 0.000618 | 0.000033 | ||
3–6 | 99.8 | 0.19 | 0.099 | 0.001988 | 0.000060 | ||
6–9 | 99.2 | 0.78 | 0.203 | 0.002360 | 0.000066 | ||
9–12 | 98.5 | 1.48 | 0.280 | 0.001004 | 0.000043 | ||
12 | 98.2 | 1.77 | 0.307 | . | . | ||